Actavis PLC (NYSE:ACT)

301.35
Delayed Data
As of May 22
 +0.13 / +0.04%
Today’s Change
201.91
Today|||52-Week Range
317.72
+17.07%
Year-to-Date

Today’s Trading

Previous close301.22
Today’s open300.52
Day’s range-- - --
Volume2,246,056
Average volume (3 months)3,174,381
Market cap$118.4B
Dividend yield--
Data as of 05/22/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.45%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.09-0.16%
BMYBristol-Myers Squibb-0.59-0.86%
GSKGlaxoSmithKline-0.30-0.66%
ABBVAbbVie-0.17-0.26%
Data as of 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$4.26
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers